Abstract :

Recent reports from various observational investigations revealed and published the outcomes of Non-insulin Anti-diabetic agents. Patients additionally with Type-II Diabetes Mellitus and coronavirus disease, caused by severe acute respiratory syndrome [SARS] has become widespread disease in the world since last 3 years. Age, sex, ethnicity, obesity and co-morbidities all apparently enhance the risk of worst consequences. Glucose lowering drugs and anti-viral drug treatment could limit the risk but impose restrictions on their usage which needs to be carefully assessed. This severe acute respiratory syndrome [coronavirus] might be a potentially triggering and worsen the aspect for the diabetic patients that can bring about severe metabolic complications effecting β-cell function leading to hyperglycaemia and diabetic ketoacidosis.

---

Keywords :

Co-morbidities, coronavirus, diabetes mellitus, Diabetic ketoacidosis, Hyperglycemia, Severe acute respiratory syndrome.

---

References :

1. Elamari S, et al. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. The Pan African medical journal 2020;37. 32-32.
2. Ceriello A. Hyperglycemia and COVID-19: what was known and what is really new? Diabetes Res Clin Pract 2020;167. 108383-108383.
3. Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev 2020; 14: 535–45.
4. Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin use IS associated with reduced mortality IN a diverse population with COVID-19 and diabetes. MedRxiv Prepr Serv Heal Sci 2020. https://doi.org/10.1101/07.29.20164020.
5. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature Awadhesh Kumar Singh a, Ritu Singh, Banshi Saboo, Anoop Misra Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 159e167.
6. Scheen AJ. Metformin and COVID-19: From cellular mechanisms to reduced mortality. Diabetes Metab 2020; 46: 423–426
7. COVID-19 in people with diabetes: understanding the reasons for worse outcomes Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, Laura Mazoni, Alberto Coppelli, Stefano Del Prato. Lancet Diabetes Endocrinol 2020: 8; 782–92 Published Online July 17, 2020 https://doi.org/10.1016/ S2213-8587(20)30238-2.
8. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 2020; 127: 104354.
9. Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a wholepopulation study. Lancet Diabetes Endocrinol 2020; published online Aug 13. https://doi.org/10.1016/S2213-8587(20)30272-2
10. Shi Q, Zhang X, Jiang F, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care 2020; 43: 1382–91.
11. Ebekozien OA, Noor N, Gallagher MP, Alonso GT. Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the US. Diabetes Care 2020; published online June 5. https//:doi.org.10.2337/dc20-1088
12. Dudley JP, Lee NT. Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clin Infect Dis 2020; published online March 31. https//:doi. org.10.1093/cid/ciaa354.
13. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Wkly 2020; 2: 113–22.
14. Lim S, et al. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 2021;17(1):11e30.
15. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 2018;34(5): 575-84.
16. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107(9):1058e70.
17. Berbudi A, et al. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 2020;16(5):442-9.
18. Sestan M, et al. Virus-induced interferon-g causes insulin resistance in skeletal muscle and derails glycemic control in obesity. Immunity 2018;49(1): 164-177.e6.
19. Swati Sharma, Avik Ray, Balakrishnan Sadasivam. “Metformin in COVID-19: A Possible Role Beyond Diabetes”, Diabetes Research and Clinical Practice, 2020
20. Unübol M, Ayhan M, Guney E. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis. J Clin Rheumatol 2011; 17: 46–47
21. Antonia Anna Lukito, Raymond Pranata, Joshua Henrina, Michael Anthonius Lim, Sherly Lawrensia, Ketut Suastika. “The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis”, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
22. Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin use IS associated with reduced mortality IN a diverse population with COVID-19 and diabetes. MedRxiv Prepr Serv Heal Sci 2020. https://doi.org/10.1101/ 2020.07.29.20164020.
23. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetetes Endocrinol 2020; 8: 546–550.
24. Scheen AJ. Metformin and COVID-19: From cellular mechanisms to reduced mortality. Diabetes Metab 2020; 46: 423–426
25. Ursini F, Ciaffi J, Landini MP, Meliconi R. COVID-19 and diabetes: is metformin a friend or foe? Diabetes Res Clin Pract 2020;164:108167. https://doi.org/ 10.1016/j.diabres.2020.108167.
26. Liu J, Li X, Lu Q, et al. AMPK: a balancer of the reninangiotensin system. Biosci Rep 2019;39(9). https://doi.org/ 10.1042/BSR20181994. BSR20181994.
27. Clements A, Gao B, Yeap SH, Wong MK, Ali SS, Gurney H. Metformin in prostate cancer: Two for the price of one. Ann Oncol 2011;22:2556–60. https://doi.org/10.1093/annonc/ mdr037
28. Lim S, et al. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 2021;17(1):11e30.
29. Hansen TK, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannosebinding lectin levels. J Clin Endocrinol Metab 2003;88(3):1082e8
30. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 2014;30(2):96e102
31. Nassar M, et al. Current systematic reviews and meta-analyses of COVID-19. World J Virol 2021;10(4):182e208.
32. Nassar, A. Daoud, N. Nso et al. Diabetes Mellitus and COVID-19: Review Article. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 102268
33. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–47.
34. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; published online May 21. https//:doi. org.10.1056/NEJMoa2015432.
35. Buja LM, Wolf D, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol 2020; 48: 107233.
36. Chen Y, et al. Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study. Engineering 2020;6(10): 1170e7.
37. Bhatt K, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries 2021:9 (1):e126
38. Song G, Liang G, Liu W. Fungal Co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 2020;185(4):599e606.
39. Heaney AK, et al. Coccidioidomycosis and COVID-19 Co-infection, United States, 2020. Emerg Infect Dis 2021;27(5):1266e73.
40. Singh AK, et al. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(4):102146.